Does Ro Take Insurance? What Wegovy and Zepbound Really Cost

Does Ro take insurance, or is it cash-pay?

It's a mix, and the split matters. The $149 membership is always self-pay. Ro never sends it to an insurer, covered or not.

The medicine is different. If your plan covers Wegovy or Zepbound and approves a prior authorization, the prescription can be filled through your insurance. Prior authorization is an approval your plan must give before it pays. You then pay your plan's copay or coinsurance instead of the cash prices below. Ro's insurance page describes this split: coverage runs through your plan at the pharmacy, while the membership stays a separate cash charge.

So you're never fully in network the way you'd be at a doctor's office. But you're not always fully cash-pay either. Which side you land on depends on what your plan says about weight-loss GLP-1s.

What Ro costs without insurance

Every Ro patient pays the same membership, covered or not. It's $149 a month, or $39 for the first month. Prepaying lowers it: $99 a month for 3 months, $89 for 6, or $74 for a year. It covers provider visits, coaching, a metabolic lab test when your provider orders it, and the insurance help described below. It doesn't include medicine.

The medicine is billed separately. Without insurance, here's what each option costs:

• Wegovy pill: $149 a month at the 1.5 mg starting dose, $199 at 4 mg, and $299 at 9 and 25 mg. It's the cheapest brand-name start on the menu.
• Wegovy pen: $199 for each of the first two fills, for new patients who sign up by December 31, 2026. Then it's $349 a month, or $399 for the stronger 7.2 mg dose.
• Foundayo pill: $149 to $299 a month by dose, with limited-time prices for sign-ups by December 31, 2026. The top doses need a refill within 45 days, or the price is $349.
• Zepbound KwikPen: $299 a month at 2.5 mg and $399 at 5 mg. From 7.5 mg up, it's $449 if you refill within 45 days, otherwise $499 at 7.5 mg and $699 from 10 mg.

Add the membership and most people pay about $300 to $600 a month. On the annual prepay, it's about $225 to $525. The pill sits at the low end, and Zepbound at a full dose sits at the top. Prices rise as your dose climbs, so price the dose you expect to reach.

Ro also lists Ozempic and Saxenda, both described as mainly insurance-dependent, with no cash price published. Ozempic is approved for type 2 diabetes, not weight loss. A weight-loss-only prescription is unlikely to get covered. Saxenda is being discontinued by its maker, with supply until January 2027. Without diabetes and without coverage, the realistic cash choices at Ro are Wegovy, Foundayo and Zepbound.

What Ro's insurance help actually includes

Insurance navigation means very different things across telehealth brands. At Ro, it's a dedicated team, not a self-service checker. Staff check your plan's coverage, prepare and send the prior authorization paperwork, talk to your insurer and file an appeal if the first request is denied.

Ro says a decision usually takes one to two weeks once the paperwork is sent. The whole process, from checking your plan to an answer, takes about two to three weeks.

One distinction matters before you count on it. Prior authorization only works for coverage your plan could grant. Some employer plans exclude weight-loss GLP-1s in writing, whatever your doctor documents. Then there's nothing to submit and no appeal to win. Ro's team can tell you which situation you're in. It can't make your employer cover a drug class the plan excludes.

How likely is insurance to cover Wegovy or Zepbound?

Ro doesn't publish an approval rate for its own patients, and neither do other GLP-1 telehealth brands. The best public data comes from employers. In 2025, about one in five firms with 200 or more workers covered GLP-1s for weight loss in their largest plan. Among firms with 5,000 or more workers, 43% did.

Even then, rules pile up. About a third of the firms that cover these drugs require a dietitian, coaching or lifestyle program first. Several large employers told researchers they were tightening coverage because costs ran higher than expected. So for most employer plans, coverage is the exception, not the rule.

If insurance says no, what do you pay?

Exactly the cash prices above, nothing more. A denied request doesn't trigger a penalty price. You pay the membership plus the medicine, as if you'd never asked.

Over a year, that's about $2,680 if you stay on the Wegovy pill's starting dose all year with the annual prepay. Following the pill's normal dose steps, it's about $4,230. Zepbound with the monthly membership comes to about $6,870 as the dose climbs. Most people land in between.

Two Lilly rules can push the Zepbound total up. Lilly's KwikPen self-pay terms cover up to 11 fills in a calendar year, and those terms end December 31, 2026. The $449 price also needs each refill within 45 days.

If you're on Medicare, look at the Medicare GLP-1 Bridge first. It charges $50 a month for Wegovy, Foundayo or the Zepbound KwikPen, for people who meet its rules.

Is Ro's insurance help worth it compared with a brand that offers none?

Compare Ro with Hers, where every plan is cash-pay with no path to your insurer. If your plan has any real chance of covering Wegovy or Zepbound, Ro's team costs nothing beyond the membership. A cash-only brand charges a membership too. Ro gives you a real attempt at turning a $300 to $450 medicine bill into a copay.

That edge disappears if your plan excludes weight-loss GLP-1s outright, or you're on Medicaid. Then the cash result at Ro and Hers is roughly the same. The choice comes down to the medicine menu and platform fit.

Can FSA or HSA money close the gap?

Partly. Prescribed GLP-1 medicine generally counts as an eligible expense for an FSA or HSA, tax-free health accounts many employers offer. But Ro doesn't accept HSA or FSA cards at checkout. You pay with a regular card, then send your receipt to your plan to be paid back.

Ask your plan whether it will pay back both the medicine and the $149 membership. If it does, paying with pre-tax money lowers your real cost by your tax rate.

Is Ro worth it if you don't have GLP-1 coverage?

If your plan might cover Wegovy or Zepbound, yes, use the insurance help before you rule Ro out on price. It costs nothing beyond the membership. Having Ro do the paperwork and appeals, instead of you on hold with your insurer, is the real difference.

If you already know the answer is no, the question is the cash price: about $300 to $600 a month, or $225 to $525 on the annual prepay. You're paying for brand-name medicine, a lab test and coaching, against cheaper compounded brands. The full Ro review covers how the program works, and the Ro cost breakdown runs the dose-by-dose math.